Valif Oral Jelly 20 mg contains the active ingredient Vardenafil, which is a phosphodiesterase type 5 (PDE5) inhibitor used primarily to treat erectile dysfunction (ED). Here's how Valif Oral Jelly 20 mg affects blood vessel health:
Mechanism of Action: Vardenafil works by inhibiting the enzyme PDE5, which is responsible for the breakdown of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells lining the blood vessels, particularly in the penis. When a man is sexually stimulated, nitric oxide is released into the erectile tissue, which activates guanylate cyclase. This enzyme increases levels of cGMP, leading to relaxation of the smooth muscles and increased blood flow into the penis, resulting in an erection.
Local Effect: Valif Oral Jelly 20 mg is typically used for its local effects on erectile function rather than systemic effects on blood vessels throughout the body. Its primary action is to enhance blood flow to the penis to facilitate an erection.